
Alcon Announces Launch of AcrySof IQ Vivity in India, the First and Only Presbyopia-Correcting Lens Implant with Proprietary Wavefront-Shaping Technology for Cataract Surgery
New Delhi (India), January 7: Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology – the AcrySof® IQ Vivity® IOL (Vivity®). This new PC-IOL is now available to Indian ophthalmologists for their patients undergoing cataract surgery. Cataracts usually impact older adults and are often linked to presbyopia, which reduces the ability to view near objects and is the most common refractive disorder in patients undergoing cataract surgery.
Vivity is the first and only extended depth of focus lens with Alcon’s proprietary X-WAVE technology, which stretches and shifts light without splitting it. Vivity delivers a continuous range of vision at various distances like monofocal-quality distance (far) with excellent intermediate (at arm’s length, e.g., reading the newspaper, working on a laptop) and functional near (up close, e.g., reading books, mobile phone), with a clinically proven exceptionally low rate of visual disturbances. Commemorating World Sight Day on October 14, Vivity aims to meet the needs of cataract patients interested in enhanced visual performance, reduced spectacle dependence while enabling more independence.
Vivity expands Alcon’s growing portfolio of PC-IOLs and is built on Alcon’s trusted and proven AcrySof IQ IOL platform with implants exceeding 125 million eyes globally. According to results from two large independent clinical trials, patients who had the Vivity lens implanted experienced renewed vision and lifestyle benefits. Vivity patients reported 20/20 vision at a distance, more than 20/25 at intermediate and 20/32 for near vision. Additionally, 94% and 92% of Vivity patients reported superior vision at distance and arm’s length, respectively, without glasses in bright light.
Cataracts are the most common cause of vision loss globally and the primary cause of preventable blindness in India. Cataract surgery involves removing the clouded natural crystalline lens followed by a replacement with an intraocular lens (IOL). The prevalence of cataracts in India is 9.9 million; each year, 6.5 million surgeries are performed by around 12,200 cataract surgeons.
Among the 6.5 million undergoing cataract surgery in India, 90% of patients continue to depend on glasses for most of their daily activities even after surgery. An independent survey revealed that 95% of these patients expressed the willingness to get rid of glasses after the surgery. Sadly, despite the desire, there are several barriers. One of the significant barriers is the limitation of the current technology to address the visual needs of all patient groups.
“Traditional IOLs typically address distance vision. The new generation of seniors spend significant time with technology screens like phones, tablets and computers, and currently experience a massive gap in near and intermediate vision post-surgery,” said Shalav Modi, Country Franchise Head, Surgical, and Country Manager at Alcon Laboratories India Pvt Ltd. “Vivity addresses this gap and the desire of patients who want to get rid of cataracts and presbyopia at the same time. As a result, patients can be less dependent on glasses for most activities post-surgery, enhancing their visual satisfaction and quality of life,” Modi added.
Vivity is the first and only non-diffractive* presbyopia-correcting IOL with minimum visual disturbance profile. Unlike conventional presbyopia-correcting IOLs, which split light, Vivity utilizes almost all light energy, providing good vision quality in all lighting conditions. Vivity is approved by the Central Drug Standard Control Organization (CDSCO).
Leading ophthalmic surgeons worldwide who have had a chance to implant Vivity have said that they can now offer presbyopia correction to a more significant number of patients undergoing cataract surgery, with strong satisfaction rates. Based on a recent survey, 93% of patients said they would definitely recommend the new AcrySof Vivity to their friends and relatives.
wonderful points altogether, you simply gained a new reader. What may you suggest in regards to your publish that you simply made some days ago? Any positive?
I am thankful that I observed this blog, exactly the right info that I was looking for! .
I am really loving the theme/design of your site. Do you ever run into any browser compatibility problems? A few of my blog readers have complained about my website not operating correctly in Explorer but looks great in Firefox. Do you have any recommendations to help fix this issue?
I am not sure where you are getting your info, but great topic. I needs to spend some time learning more or understanding more. Thanks for magnificent info I was looking for this information for my mission.
Do you have a spam issue on this blog; I also am a blogger, and I was wondering your situation; we have created some nice methods and we are looking to swap strategies with other folks, be sure to shoot me an e-mail if interested.
Just wanna comment on few general things, The website style and design is perfect, the subject material is really excellent. “The way you treat yourself sets the standard for others.” by Sonya Friedman.
Definitely believe that which you stated. Your favorite justification appeared to be on the internet the easiest thing to be aware of. I say to you, I definitely get irked while people think about worries that they plainly don’t know about. You managed to hit the nail upon the top and also defined out the whole thing without having side-effects , people could take a signal. Will probably be back to get more. Thanks
What¦s Happening i’m new to this, I stumbled upon this I have discovered It absolutely useful and it has aided me out loads. I’m hoping to contribute & aid other users like its helped me. Great job.
I am really loving the theme/design of your web site. Do you ever run into any browser compatibility problems? A small number of my blog readers have complained about my site not operating correctly in Explorer but looks great in Opera. Do you have any suggestions to help fix this problem?
Hello.This post was really interesting, particularly since I was searching for thoughts on this matter last Monday.
I’ve been surfing on-line more than 3 hours today, but I never found any interesting article like yours. It?¦s beautiful price enough for me. Personally, if all site owners and bloggers made good content material as you did, the internet can be a lot more useful than ever before.
This web site is really a walk-through for all of the info you wanted about this and didn’t know who to ask. Glimpse here, and you’ll definitely discover it.
Enjoyed looking at this, very good stuff, appreciate it.
I appreciate, cause I found exactly what I was looking for. You’ve ended my four day long hunt! God Bless you man. Have a great day. Bye
I was examining some of your blog posts on this internet site and I believe this internet site is real informative ! Keep putting up.
I like what you guys are up also. Such intelligent work and reporting! Carry on the excellent works guys I have incorporated you guys to my blogroll. I think it will improve the value of my web site 🙂